Clearance Summary
ZOLL PROPAQ MD received FDA 510(k) clearance under submission number K100654, sponsored by Zoll Medical Corporation, World Wide Headquarters. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2010-07-29.
- Submission: K100654
- Applicant / Sponsor: Zoll Medical Corporation, World Wide Headquarters
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.5300
- Decision date: 2010-07-29
Classification & Regulation
This clearance is catalogued under FDA product code LDD and 21 CFR 870.5300, within the Cardiovascular review panel as a Class II device.